Preliminary Results of Hyperthermic Intraperitoneal Intraoperative Chemotherapy as an Adjuvant in Resectable Pancreatic Cancer

Figure 1

Overall survival of 21 patients with pancreatic cancer treated with complete resection plus hyperthermic intraoperative intraperitoneal chemotherapy.